# Biomm signs 10-year insulin supply deal with Brazil

*Agreement involves tech transfer with Fiocruz and China’s Gan & Lee Pharmaceuticals*

- Published: 2025-09-23
- Section: Insights
- Tags: Biomm glargine supply, Biomm Health Ministry, Biomm insulin contract
- URL: https://brazilstockguide.com/insights/biomm-insulin-deal-health-ministry/

![Biomm insulin deal](https://i0.wp.com/brazilstockguide.com/wp-content/uploads/2025/09/insulina_teste_05082110263.webp?fit=1024%2C613&ssl=1)

*Biomm signs 10-year insulin deal with Health Ministry (Image/Agência Brasil)*

**By Brazil Stock Guide –** Biomm SA (BIOM3:SA) said it has signed a technology transfer contract to supply insulin glargine to Brazil’s Ministry of Health. The 10-year deal consolidates a broader partnership that also includes Bio-Manguinhos/Fiocruz and China’s Gan & Lee Pharmaceuticals.

The long-acting insulin analogue, used in the treatment of type 1 and type 2 diabetes, will be produced at Biomm’s facility in Nova Lima, Minas Gerais. The company said it has invested about 800 million reais ($142 million) in the plant.

“This contract consolidates the commitment of the Productive Development Partnership (PDP) signed between the Ministry of Health, Bio-Manguinhos/Fiocruz, Biomm and Gan & Lee Pharmaceuticals, enabling the immediate supply of insulin glargine to the Ministry of Health for 10 years,” Biomm said in its filing.

Biomm’s main shareholders include investment fund Cartago, with a 25.86% stake, the Walfrido group with 8.01%, and Brazil’s state development bank BNDES with 5.12%.

---

Source: Brazil Stock Guide, https://brazilstockguide.com/insights/biomm-insulin-deal-health-ministry/